Skip to main content

Table 2 Univariate analysis of TRPV6 expression and clinicopathological factors for disease specific survival in patients with ESCC

From: TRPV6 plays a new role in predicting survival of patients with esophageal squamous cell carcinoma

Characteristic

mRNA cohort

Protein cohort

3-year DSS (%)

P a

3-year DSS (%)

P a

TRPV6 expression

Ā 

0.531

Ā 

0.244

ā€ƒDownregulation

53.8

Ā 

34.0

Ā 

ā€ƒNormal expression

59.6

Ā 

42.9

Ā 

Age

Ā 

0.145

Ā 

0.448

ā€ƒā€‰ā‰¤ā€‰58

60.6

Ā 

38.9

Ā 

ā€ƒā€‰>ā€‰58

55.3

Ā 

38.1

Ā 

Gender

Ā 

0.653

Ā 

0.880

ā€ƒMale

58.1

Ā 

40.2

Ā 

ā€ƒFemale

55.9

Ā 

37.2

Ā 

Location

Ā 

0.545

Ā 

0.428

ā€ƒUpper

64.4

Ā 

30.6

Ā 

ā€ƒMiddle

56.1

Ā 

40.1

Ā 

ā€ƒLower

55.2

Ā 

47.1

Ā 

Differentiation

Ā 

0.330

Ā 

0.010

ā€ƒGrade 1

62.6

Ā 

54.2

Ā 

ā€ƒGrade 2

60.7

Ā 

40.8

Ā 

ā€ƒGrade 3

45.4

Ā 

23.4

Ā 

pT category

Ā 

0.040

Ā 

0.002

ā€ƒT1ā€“2

66.4

Ā 

52.5

Ā 

ā€ƒT3ā€“4

55.6

Ā 

30.4

Ā 

pN category

Ā 

<0.001

Ā 

<0.001

ā€ƒN0

74.0

Ā 

54.0

Ā 

ā€ƒN1ā€“3

37.5

Ā 

18.1

Ā 

Pathological staging

Ā 

<0.001

Ā 

<0.001

ā€ƒIā€“II

72.1

Ā 

53.3

Ā 

ā€ƒIII

37.5

Ā 

13.6

Ā 
  1. aKaplan-Meier method (log-rank test)
  2. DSS, disease specific survival